The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate
Conditions
Prostate Cancer
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Intervention
Name: Goldlock Type: Device
Name: Visicoil smallest size Type: Device
Name: Visicoil larger size Type: Device
Name: Bard goldmarker smallest size Type: Device
Name: Bard goldmarker larger size Type: Device
Overall Status
Recruiting
Summary
Implantation of fiducial markers in the prostate and daily check of the positioning during radiotherapy based on the implanted fiducial markers
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Male
Criteria: Inclusion Criteria:

- histological proven adenocarcinoma of the prostate

- T1-T4 tumors

- Radiotherapy as primary therapy +/- androgen deprivation

- Presence of an intraprostatic lesion (IPL) on MRI/MRS

- Presence of an intraprostatic lesion (IPL) on ultrasound

- WHO 0-2

Exclusion Criteria:

- Other primary tumor, except non-melanoma skin cancer

- No written informed consent
Location
University Hospital Ghent
Ghent, Belgium
Status: Recruiting
Start Date
December 2008
Completion Date
May 2015
Sponsors
University Hospital, Ghent
Source
University Hospital, Ghent
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page